Acyclovir Injection Shortage

• • Acyclovir sodium injection, Eugia US, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0154-10
  • Acyclovir sodium injection, Eugia US, 50 mg/mL, 20 mL vial, 10 count, NDC 55150-0155-20
  • Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 10 mL vial, 10 count, NDC 63323-0325-10
  • Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 20 mL vial, 10 count, NDC 63323-0325-20

• • Eugia did not provide a reason for the shortage.
  • Fresenius Kabi has acyclovir on shortage due to increased demand.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Eugia has acyclovir sodium 50 mg/mL 10 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
  • Fresenius Kabi has acyclovir sodium 50 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-May 2024 for the 10 mL vials and mid- to late-June 2024 for the 20 mL vials.